Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge
- 1 January 2013
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 31 (2), 319-326
- https://doi.org/10.1016/j.vaccine.2012.11.007
Abstract
No abstract availableKeywords
Funding Information
- NIAID Middle Atlantic Regional Center of Excellence (MARCE) grant (U54 AI057168)
This publication has 41 references indexed in Scilit:
- Effect of the strength of adsorption of HIV 1 SF162dV2gp140 to aluminum‐containing adjuvants on the immune responseJournal of Pharmaceutical Sciences, 2011
- Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc ReceptorsPLOS ONE, 2011
- A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challengeVaccine, 2010
- Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primatesVaccine, 2009
- Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5Journal of Virology, 2009
- Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune responseVaccine, 2009
- Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on ComplementJournal of Virology, 2009
- Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigensVirology, 2008
- Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challengesVaccine, 2007
- A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boostVaccine, 2007